Matches in Wikidata for { <http://www.wikidata.org/entity/Q80654226> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q80654226 description "article scientifique publié en 2008" @default.
- Q80654226 description "artículu científicu espublizáu en marzu de 2008" @default.
- Q80654226 description "im März 2008 veröffentlicher wissenschaftlicher Artikel" @default.
- Q80654226 description "scientific article published on 01 March 2008" @default.
- Q80654226 description "wetenschappelijk artikel" @default.
- Q80654226 description "наукова стаття, опублікована в березні 2008" @default.
- Q80654226 name "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 name "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 type Item @default.
- Q80654226 label "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 label "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 prefLabel "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 prefLabel "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 P1433 Q80654226-4C55D88E-6991-4F94-9DC9-724439BB5695 @default.
- Q80654226 P1476 Q80654226-5F07B8FB-6BA2-49BC-A398-217742A0B380 @default.
- Q80654226 P2093 Q80654226-AAB0FB16-76D5-4EC7-B8F1-7259CC69C5BE @default.
- Q80654226 P2093 Q80654226-B1871AED-5EC9-415C-8857-72C5359A289A @default.
- Q80654226 P304 Q80654226-EE1942AD-D971-4322-A758-233F53095157 @default.
- Q80654226 P31 Q80654226-890EC48E-2331-4446-AB40-D61A7EAE770B @default.
- Q80654226 P356 Q80654226-DF4FDBBC-8E79-4993-B8B5-991DDE52A4C7 @default.
- Q80654226 P433 Q80654226-DD498EEE-71D3-446B-92CA-729CC0EC0122 @default.
- Q80654226 P478 Q80654226-1675B7BA-7C33-44B0-B7FC-C96C343AF6A5 @default.
- Q80654226 P50 Q80654226-A8BF3A9E-D6FD-4325-A29E-AED7A5F18606 @default.
- Q80654226 P577 Q80654226-BF8DDBB9-340E-437D-849E-BB541B3C58E1 @default.
- Q80654226 P698 Q80654226-20D60149-5926-40E5-8F43-1E3F66C850D6 @default.
- Q80654226 P921 Q80654226-5015CB0B-475B-4B29-92F7-A12D14BD48C2 @default.
- Q80654226 P356 J.1399-3038.2007.00658.X @default.
- Q80654226 P698 18257907 @default.
- Q80654226 P1433 Q14064731 @default.
- Q80654226 P1476 "Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease" @default.
- Q80654226 P2093 "P C Doré" @default.
- Q80654226 P2093 "W A C Sewell" @default.
- Q80654226 P304 "186-187" @default.
- Q80654226 P31 Q13442814 @default.
- Q80654226 P356 "10.1111/J.1399-3038.2007.00658.X" @default.
- Q80654226 P433 "2" @default.
- Q80654226 P478 "19" @default.
- Q80654226 P50 Q42348152 @default.
- Q80654226 P577 "2008-03-01T00:00:00Z" @default.
- Q80654226 P698 "18257907" @default.
- Q80654226 P921 Q265936 @default.